HuGE Literature Finder
Records 1-10
|
Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
Neurosurgery 2020 Dec . Dono Antonio, Takayasu Takeshi, Yan Yuanqing, Bundrant Bethany E, Arevalo Octavio, Lopez-Garcia Carlos A, Esquenazi Yoshua, Ballester Leomar |
|
Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
BMC cancer 2019 Apr 19 (1): 313. Shahi Rajendra Bahadur, De Brakeleer Sylvia, Caljon Ben, Pauwels Ingrid, Bonduelle Maryse, Joris Sofie, Fontaine Christel, Vanhoeij Marian, Van Dooren Sonia, Teugels Erik, De Grève Jacqu |
|
Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
The American journal of surgical pathology 2016 Jan . Huang Shih-Chiang, Zhang Lei, Sung Yun-Shao, Chen Chun-Liang, Kao Yu-Chien, Agaram Narasimhan P, Singer Samuel, Tap William D, D'Angelo Sandra, Antonescu Cristina |
|
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy.
Oncotarget 2015 Aug 6 (22): 19305-15. Berardi Rossana, Brunelli Alessandro, Pagliaretta Silvia, Paolucci Vittorio, Conti Alessandro, Goteri Gaia, Refai Majed, Pompili Cecilia, Marcantognini Giulia, Morgese Francesca, Ballatore Zelmira, Savini Agnese, De Lisa Mariagrazia, Caramanti Miriam, Santoni Matteo, Zizzi Antonio, Piva Francesco, Mazzanti Paola, Onofri Azzurra, Sabbatini Armando, Scarpelli Marina, Cascinu Stefa |
|
Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.
Human pathology 2014 Aug 45 (8): 1563-71. Jour George, Scarborough John D, Jones Robin L, Loggers Elizabeth, Pollack Seth M, Pritchard Colin C, Hoch Benjamin |
|
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients.
Pharmacogenomics 2013 Dec 14 (16): 1991-8. Scartozzi Mario, Giampieri Riccardo, Loretelli Cristian, Bittoni Alessandro, Mandolesi Alessandra, Faloppi Luca, Bianconi Maristella, Del Prete Michela, Andrikou Kalliopi, Bearzi Italo, Cascinu Stefa |
|
Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Apr 18 (8): 2382-90. Finegold David N, Baty Catherine J, Knickelbein Kelly Z, Perschke Shelley, Noon Sarah E, Campbell Diana, Karlsson Jenny M, Huang Diana, Kimak Mark A, Lawrence Elizabeth C, Feingold Eleanor, Meriney Stephen D, Brufsky Adam M, Ferrell Robert |
|
Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib.
Investigational new drugs 2011 Oct 29 (5): 953-62. Steeghs Neeltje, Mathijssen Ron H J, Wessels Judith A M, de Graan Anne-Joy, van der Straaten Tahar, Mariani Mariangela, Laffranchi Bernard, Comis Silvia, de Jonge Maja J A, Gelderblom Hans, Guchelaar Henk-J |
|
Association of genetic markers in angiogenesis- or exposure-related genes with overall survival in pazopanib (P) treated patients (Pts) with advanced renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Mar 29 (7_suppl): 303. Xu C, Ball H A, Bing N, Sternberg C N, Xue Z, McCann L, King K, Spraggs C F, Mooser V E, Pandite L |
|
HGF and MET mutations in primary and secondary lymphedema.
Lymphatic research and biology 2008 6 (2): 65-8. Finegold David N, Schacht Vivien, Kimak Mark A, Lawrence Elizabeth C, Foeldi Etelka, Karlsson Jenny M, Baty Catherine J, Ferrell Robert |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: